
Scott Brunner
Scott Brunner is the CEO of the Alliance for Pharmacy Compounding, an organization that represents the interests of compounding pharmacies. He provides insights into the legal and regulatory landscape surrounding compounded medications, particularly as they relate to shortages of FDA-approved drugs and the implications of telehealth prescriptions in the evolving healthcare market.
Power26,923
Reach424,362
Country presence
Recent news mentions
Scott Brunner is the chief executive officer of the Alliance for Pharmacy Compounding.
FDA advisers support easing restrictions on six peptides. Here’s what those drugs are and what happens nextCNN·
United States· 2026-07-31
Scott Brunner, chief executive officer of the Alliance for Pharmacy Compounding, sent a public letter to the committee in support of adding peptides to the list.
The future of peptides in the US is about to become clearer. Here’s what you should knowCNN·
United States· 2026-07-23
Scott Brunner is the CEO of the Alliance for Pharmacy Compounding.
What is compounded semaglutide? All you need to know about the weight loss drugs Hims & Hers is sellingThe Times of India·
India· 2025-02-11
Also mentioned
Shabbir Imber Safdar










